Researchers Identify Genes Linked to Relapse in Standard-Risk B-Cell Acute Lymphoblastic Leukemia

Researchers have identified genetic variations that influence relapse risk in children with standard-risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood cancer. The discovery provides a basis for improved diagnosis, precise tailoring of treatment intensity and potentially the development of novel therapeutic approaches, according to the study researchers from St. Jude Children’s Research Hospital, Seattle Children’s and the Children’s Oncology Group.